Spravato

Spravato is a breakthrough intranasal ketamine treatment that is FDA-approved for treatment-resistant depression. This therapy offers rapid relief from symptoms of depression, particularly for individuals who have not found success with traditional antidepressants. Administered in a clinical setting under the supervision of a healthcare professional, Spravato is known for its fast-acting benefits, providing patients with a new avenue for mental health recovery.

Covered by insurance, Spravato is an accessible treatment option for those in need of immediate symptom relief. Whether you're dealing with chronic depression or anxiety, this FDA-cleared treatment may be the solution you’ve been seeking. With a quick onset and long-lasting benefits, Spravato helps patients regain stability and clarity, making it an essential tool for managing treatment-resistant mental health conditions.